Hui Yuwen

893 ATG-101, a novel PD-L1/4–1BB bispecific antibody, augments anti-tumor immunity through immune checkpoint inhibition and PDL1-directed 4–1BB activation

Yijing Ren, J. Mei, Bing Hou, 2021, Journal for ImmunoTherapy of Cancer.

Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis.

M. Hemann, P. M. Bruno, C. Clish, 2017, Cancer research.